Infectious disease – Page 3 – NCAL Research Spotlight

Pregnancy history of red-blood-cell donors not linked to higher mortality in transfusion recipients

June 11, 2019
Health Policy, Hospital systems, Infectious disease
0 Comments

Division of Research investigators participated in a multi-institution collaborative analysis, which supported the safety of current transfusion practice within Kaiser Permanente’s network of community hospitals.

Waning potency of pertussis vaccine a significant contributor to recent whooping cough outbreaks

June 9, 2019
Adolescent Health, Children’s health, Infectious disease, Press Release, Vaccine research, Vaccines
0 Comments

Children who were up to date on their pertussis vaccine schedule were far less likely to develop the disease than those unvaccinated. The risk of vaccinated children becoming ill increased with time since vaccination, suggesting waning effectiveness.

Hepatitis C drugs not associated with more adverse events

Direct-acting antiviral agents used to treat patients with the hepatitis C virus are not associated with higher rates of adverse liver, kidney, and cardiovascular events, according to research published in JAMA Network Open and supported by data from Kaiser Permanente Northern California.

The New Faces of Health Care Research, Pt. 2

January 30, 2019
Alcohol and drug, Cardiovascular, Feature, Infectious disease, telehealth, Vaccine research, Vaccines
0 Comments

In part 2 of our profile series, meet the last three of the seven early-career researchers who began their post-doctoral appointments this past year and represent not only diverse communities but diverse research interests as well.

The New Faces of Health Care Research

January 22, 2019
Autism, Cardiovascular, Comparative Effectiveness Research, Delivery Science, Feature, Hospital systems, Infectious disease, Vaccine research
0 Comments

Seven early-career researchers began their post-doctoral appointments this past year and represent not only diverse communities but diverse research interests as well. This is Part 1 of our new class profile.

5 Questions for…Michael Silverberg

November 28, 2018
5 Questions, Feature, Infectious disease
0 Comments

With December 1 marking World AIDS Day, this infectious disease expert looks at the state of HIV/AIDS research. And despite his Northern California location, admits he's a diehard Los Angeles Lakers fan.

Kaiser Permanente Research Featured at ID Week 2018

October 16, 2018
Infectious disease
0 Comments

Kaiser Permanente Division of Research scientists recently presented research on influenza vaccines, colorectal screening outcomes in HIV-infected individuals, a genetic basis for fever after measles-containing vaccines, and more at ID Week, a leading conference on infectious diseases.

Q&A: Talking Flu Shots with Nicola Klein, Director of Kaiser Permanente’s Vaccine Study Center

Dr. Klein’s latest research raised some interesting questions about when influenza vaccinations are most effective, so we spoke with her to learn more and answer some common flu vaccine questions.

“Catch-up” HPV Vaccination Works for Females up to Age 20 Years at First Dose, Not Older Ages

August 7, 2018
Behavioral health, Children’s health, Infectious disease, Women’s health
0 Comments

Kaiser Permanente study confirms recommendations for catch-up HPV vaccination with 3 doses in females aged 15 to 20, but not when started at or after age 21.

Eight Weeks or Twelve? Kaiser Permanente Study Shows Shorter Hepatitis C Regimen Effective in Black Patients

March 15, 2018
Disparities, Infectious disease, Uncategorized, Vaccine research, Vaccines
0 Comments

A new study shows that a treatment regimen of 8 weeks for hepatitis C may be just as effective as 12 weeks in black patients. The study also showed that more people overall can take advantage of the shorter treatment durations, which has important implications for access given the medication’s high cost.